How It Works?
Hormone Mimicking
Mimics GLP-1 and GIP hormones naturally secreted after meals, triggering insulin production for better metabolic control.
Appetite Control
Slows gastric emptying and signals satiety through brain receptors, naturally reducing hunger and cravings.
24.6%
Avg Weight Loss
72
Week Trials
VLS Tirzepatide
Clinical-Grade Weight Loss
-
✓FDA approved in 2023
-
✓Powerful appetite suppressant
-
✓Regulates blood sugar levels
-
✓Improves cardiovascular health
-
✓Optimizes lipid levels
Available Now • Prescription Free
Frequently Asked Questions
Everything you need to know about VLS Tirzepatide
What is VLS Tirzepatide?
+
When should I not use VLS Tirzepatide?
+
- You or any family members have had medullary thyroid carcinoma (MTC)
- You have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- You are allergic to Tirzepatide or any of its ingredients
How should I use VLS Tirzepatide?
+
- Inject under the skin of your stomach, thigh, or upper arm (not into muscle or vein)
- Use once weekly, same day each week, any time of day
- Can be taken with or without food
- Rotate injection sites each week
Take within 5 days of missed dose. If more than 5 days have passed, skip and take next dose on regular schedule.
Important:Never share your pen with others, even with a new needle. Continue your prescribed diet and exercise program.
What are the possible side effects?
+
- Pancreatitis: Severe stomach pain that won’t go away
- Vision Changes: Blurred vision or eye problems
- Low Blood Sugar: Dizziness, confusion, sweating, fast heartbeat
- Kidney Problems: Dehydration from severe nausea/vomiting
- Allergic Reactions: Face/throat swelling, breathing problems, severe rash
- Gallbladder Issues: Upper stomach pain, yellowing of skin/eyes
Common Side Effects: Nausea, vomiting, diarrhea, stomach pain, and constipation. These often improve over time.
Have more questions? We’re here to help!
Contact SupportUsage
Initial Dose Escalation Schedule
Weeks 1 through 4: 2.5 mg subcutaneously once a week
Weeks 5 through 8: 5 mg subcutaneously once a week
Weeks 9 through 12: 7.5 mg subcutaneously once a week
Weeks 13 through 16: 10 mg subcutaneously once a week
Maintenance Dose
Week 17 and onward: 10 mg subcutaneously once a week
Important Dosing Information
If dose escalation is not tolerated, consider delaying dose escalation for 4 weeks
Do not increase dose if desired results are achieved at a lower dose. Most people maintain at 5mg per week
Instructions
Complete step-by-step guide for administering your VLS Tirzepatide injection
📋
View All 19 Injection Steps
Click to expand detailed instructions with illustrations
+
View All 19 Injection Steps
Click to expand detailed instructions with illustrations
Step 1: Prepare
- Wash your hands with soap and water.
- Check the name and colored label of your pen, to make sure that it contains VLS Tirzepatide. This is especially important if you take more than 1 type of medicine.
- Pull off the pen cap.
Step 2: Check Medicine
Check that the VLS Tirzepatide medicine in your pen is full. VLS Tirzepatide under very cold conditions can look cloudy, this will resolve at room temperature and does not affect the product.
Step 3: Attach Needle
- Take a new needle, and tear off the paper tab.
- Do not attach a new needle to your pen until you are ready to give your injection.
Step 4: Push Needle On
Push the needle straight onto the pen. Turn until it is on tight.
Step 5: Remove Outer Cap
- The needle is covered by 2 caps. You must remove both caps. If you forget to remove both caps, you will not inject any medicine.
- Pull off the outer needle cap. Do not throw it away.
Step 6: Remove Inner Cap
Pull off the inner needle cap and throw it away.
Step 7: Flow Check
- Check the VLS Tirzepatide flow before the first injection with each new pen only.
- Turn the dose selector until the dose counter shows the flow check symbol ⚫⚫⚫
Step 8: Prime Pen
- Hold the pen with the needle pointing up. Press and hold in the dose button until the dose counter shows 0. The 0 must line up with the dose pointer. A drop of VLS Tirzepatide will appear at the needle tip.
- If no drop appears, repeat Step 7 above as shown in Figure G and Figure H up to 6 times.
- If there is still no drop, change the needle and repeat Step 7 as shown in Figure G and Figure H, 1 more time.
Do not use the pen if a drop of VLS Tirzepatide still does not appear. Contact at vls-pen@protonmail.com.
Step 9: Select Your Dose
- Turn the dose selector until the dose counter stops and shows your 2 mg dose. The dashed line in the dose counter (—) will guide you to 2 mg.
- Always use the dose counter and the dose pointer to see that 2 mg has been selected. You will hear a “click” every time you turn the dose selector. Do not set the dose by counting the number of clicks you hear. Only doses of 2 mg can be selected with the dose selector.
Step 10: Check Remaining Dose
To see how much VLS Tirzepatide is left in your pen, use the dose counter:
- Turn the dose selector until the dose counter stops.
- If it shows 1, at least 1 mg is left in your pen. If the dose counter stops before 1 mg, there is not enough VLS Tirzepatide left for a full dose of 1 mg.
If there is not enough VLS Tirzepatide left in your pen for a full dose, do not use it. Use a new VLS Tirzepatide pen.
Step 11: Choose Injection Site
Inject your dose
Choose your injection site and wipe the skin with an alcohol swab. Let the injection site dry before you inject your dose (See Figure K).
Step 12: Insert Needle
- Insert the needle into your skin as your healthcare provider has shown you.
- Make sure you can see the dose counter. Do not cover it with your fingers. This could stop the injection.
Step 13: Inject Dose
- Press and hold down the dose button until the dose counter shows 0.
- The 0 must line up with the dose pointer. You may then hear or feel a click.
- Continue pressing the dose button while keeping the needle in your skin.
Step 14: Count to 5
- Keep holding the dose button down. Count slowly to 5, and then pull the needle out of your skin.
- If you see blood at the injection site, press lightly with a gauze pad or cotton ball. Do not rub the area.
Step 15: After Injection
- Remove the needle from your skin. You can then release the dose button.
- If blood appears at the injection site, press lightly with a gauze pad or cotton ball.
Do not rub the area.
Step 16: Remove Needle
After your injection
Carefully remove the needle from the pen. Do not put the needle caps back on the needle to avoid needle sticks.
Step 17: Dispose of Needle
Place the needle in a sharps disposal container right away to reduce the risk of needle sticks.
Step 18: Replace Pen Cap
Put the pen cap on your pen after each use to protect VLS Tirzepatide from light.
Step 19: Alternative Disposal
- If you do not have a sharps disposal container, follow a 1-handed needle recapping method. Carefully slip the needle into the outer needle cap. Dispose of the needle in a sharps disposal container as soon as possible.
- Never try to put the inner needle cap back on the needle. Always remove the needle from your pen.
- Always dispose of the needle after each injection.
Quick Reference
Weekly Schedule
Always inject on the same day each week. Set reminders to maintain consistency.
Rotate Sites
Change injection sites each week to prevent irritation and ensure proper absorption.
Storage
Store in refrigerator at 36-46°F. Can be kept at room temperature for up to 21 days.
